 Roberta Pelanda
Concepts (397)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 53 | 2024 | 857 | 8.070 |
Why?
| | Receptors, Antigen, B-Cell | 28 | 2023 | 132 | 4.620 |
Why?
| | Autoimmunity | 11 | 2022 | 906 | 2.590 |
Why?
| | Central Tolerance | 4 | 2022 | 10 | 2.580 |
Why?
| | Cell Differentiation | 17 | 2024 | 1999 | 2.480 |
Why?
| | Immune Tolerance | 10 | 2025 | 374 | 2.430 |
Why?
| | Precursor Cells, B-Lymphoid | 6 | 2023 | 41 | 2.080 |
Why?
| | Autoantibodies | 11 | 2022 | 1474 | 1.540 |
Why?
| | Lupus Erythematosus, Systemic | 3 | 2022 | 234 | 1.420 |
Why?
| | B-Lymphocyte Subsets | 6 | 2018 | 78 | 1.330 |
Why?
| | Plasma Cells | 2 | 2024 | 74 | 1.220 |
Why?
| | T-Lymphocytes | 11 | 2022 | 2003 | 1.140 |
Why?
| | Autoantigens | 7 | 2021 | 425 | 1.070 |
Why?
| | Mice | 66 | 2025 | 18057 | 1.060 |
Why?
| | Phosphatidylinositol 3-Kinases | 4 | 2024 | 368 | 1.020 |
Why?
| | Cell Proliferation | 6 | 2024 | 2497 | 0.970 |
Why?
| | Animals | 75 | 2025 | 37579 | 0.890 |
Why?
| | Proto-Oncogene Proteins c-maf | 1 | 2024 | 3 | 0.890 |
Why?
| | Receptors, CXCR4 | 2 | 2024 | 89 | 0.880 |
Why?
| | Germinal Center | 2 | 2024 | 66 | 0.860 |
Why?
| | Signal Transduction | 18 | 2023 | 5148 | 0.860 |
Why?
| | Forkhead Box Protein O1 | 1 | 2024 | 35 | 0.850 |
Why?
| | Mice, Knockout | 21 | 2025 | 3064 | 0.830 |
Why?
| | Spleen | 9 | 2024 | 522 | 0.820 |
Why?
| | Alleles | 5 | 2024 | 883 | 0.800 |
Why?
| | CD8-Positive T-Lymphocytes | 8 | 2025 | 915 | 0.750 |
Why?
| | Mice, Transgenic | 15 | 2021 | 2176 | 0.720 |
Why?
| | Mice, Inbred BALB C | 15 | 2021 | 1271 | 0.710 |
Why?
| | Immunoglobulin Light Chains | 7 | 2014 | 51 | 0.710 |
Why?
| | Receptors, Lysophosphatidic Acid | 7 | 2025 | 35 | 0.660 |
Why?
| | Antibody Formation | 5 | 2018 | 297 | 0.660 |
Why?
| | Models, Animal | 4 | 2019 | 393 | 0.650 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2019 | 7 | 0.610 |
Why?
| | Immune System | 3 | 2021 | 183 | 0.600 |
Why?
| | Bone Marrow Cells | 5 | 2022 | 326 | 0.560 |
Why?
| | Mice, Inbred C57BL | 21 | 2025 | 5895 | 0.560 |
Why?
| | B-Cell Activation Factor Receptor | 5 | 2018 | 13 | 0.550 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 3 | 2018 | 174 | 0.530 |
Why?
| | Mice, Inbred MRL lpr | 4 | 2022 | 38 | 0.520 |
Why?
| | Lysophospholipids | 4 | 2023 | 78 | 0.520 |
Why?
| | Lymphocyte Activation | 9 | 2025 | 1141 | 0.520 |
Why?
| | Antigens, CD | 7 | 2015 | 544 | 0.500 |
Why?
| | MAP Kinase Signaling System | 1 | 2018 | 324 | 0.480 |
Why?
| | Flow Cytometry | 10 | 2022 | 1195 | 0.470 |
Why?
| | Bone Marrow | 5 | 2023 | 301 | 0.460 |
Why?
| | Immunoglobulin kappa-Chains | 6 | 2015 | 24 | 0.420 |
Why?
| | Gene Rearrangement, B-Lymphocyte | 4 | 2007 | 7 | 0.410 |
Why?
| | ras Proteins | 1 | 2014 | 145 | 0.400 |
Why?
| | Immunoglobulin M | 7 | 2023 | 287 | 0.400 |
Why?
| | Receptors, Cytokine | 1 | 2013 | 36 | 0.400 |
Why?
| | Tumor Virus Infections | 2 | 2012 | 50 | 0.390 |
Why?
| | Immunoglobulins | 3 | 2012 | 167 | 0.380 |
Why?
| | Glucocorticoid-Induced TNFR-Related Protein | 1 | 2012 | 5 | 0.370 |
Why?
| | Rhadinovirus | 1 | 2012 | 20 | 0.370 |
Why?
| | Gene Rearrangement, B-Lymphocyte, Heavy Chain | 3 | 2002 | 12 | 0.370 |
Why?
| | Peripheral Tolerance | 3 | 2022 | 15 | 0.360 |
Why?
| | Guanine Nucleotide Exchange Factors | 5 | 2011 | 66 | 0.350 |
Why?
| | Interleukin Receptor Common gamma Subunit | 1 | 2011 | 14 | 0.350 |
Why?
| | Transplantation Chimera | 1 | 2011 | 59 | 0.340 |
Why?
| | Immunologic Memory | 2 | 2013 | 359 | 0.340 |
Why?
| | Immunoglobulin Heavy Chains | 7 | 2013 | 85 | 0.340 |
Why?
| | Herpesviridae Infections | 1 | 2012 | 148 | 0.340 |
Why?
| | Lymph Nodes | 2 | 2013 | 500 | 0.330 |
Why?
| | Genetic Variation | 1 | 2015 | 994 | 0.330 |
Why?
| | Immunoglobulin G | 4 | 2024 | 897 | 0.330 |
Why?
| | Cytokines | 4 | 2023 | 2092 | 0.330 |
Why?
| | Genes, Immunoglobulin | 5 | 2000 | 29 | 0.320 |
Why?
| | Disease Models, Animal | 11 | 2025 | 4407 | 0.290 |
Why?
| | Immunity, Humoral | 3 | 2014 | 116 | 0.290 |
Why?
| | Immunoglobulin Allotypes | 1 | 2007 | 9 | 0.270 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2021 | 670 | 0.270 |
Why?
| | DNA-Binding Proteins | 5 | 2011 | 1478 | 0.270 |
Why?
| | Immunoglobulin Variable Region | 6 | 2007 | 81 | 0.260 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2020 | 199 | 0.260 |
Why?
| | Gene Expression Regulation | 5 | 2018 | 2604 | 0.260 |
Why?
| | Transgenes | 2 | 2018 | 185 | 0.250 |
Why?
| | Immunologic Surveillance | 2 | 2025 | 26 | 0.250 |
Why?
| | Antigens, CD19 | 4 | 2015 | 137 | 0.250 |
Why?
| | Immunoglobulin Joining Region | 4 | 2002 | 10 | 0.250 |
Why?
| | Integrases | 3 | 2006 | 123 | 0.240 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2018 | 851 | 0.240 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2025 | 22 | 0.240 |
Why?
| | RNA Editing | 1 | 2005 | 26 | 0.240 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2025 | 33 | 0.230 |
Why?
| | Immunoglobulin Isotypes | 2 | 2022 | 36 | 0.230 |
Why?
| | Antigens | 3 | 2013 | 361 | 0.230 |
Why?
| | Antibodies, Neutralizing | 3 | 2020 | 321 | 0.220 |
Why?
| | Humans | 33 | 2023 | 140898 | 0.220 |
Why?
| | Hybridomas | 3 | 2012 | 236 | 0.220 |
Why?
| | Biliary Atresia | 2 | 2018 | 153 | 0.220 |
Why?
| | Proto-Oncogene Proteins | 4 | 2010 | 624 | 0.210 |
Why?
| | Cells, Cultured | 8 | 2019 | 4199 | 0.210 |
Why?
| | Cell Separation | 4 | 2018 | 317 | 0.210 |
Why?
| | Cell Survival | 5 | 2025 | 1129 | 0.200 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2023 | 26 | 0.200 |
Why?
| | CD79 Antigens | 4 | 2018 | 16 | 0.190 |
Why?
| | Enzyme Activation | 2 | 2018 | 801 | 0.190 |
Why?
| | HIV-1 | 2 | 2020 | 880 | 0.190 |
Why?
| | Neoplasms | 3 | 2022 | 2718 | 0.190 |
Why?
| | Immunological Synapses | 1 | 2022 | 17 | 0.190 |
Why?
| | Tumor Microenvironment | 3 | 2022 | 699 | 0.190 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 467 | 0.180 |
Why?
| | Carcinogenesis | 3 | 2019 | 215 | 0.180 |
Why?
| | Models, Immunological | 3 | 2018 | 101 | 0.180 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 398 | 0.180 |
Why?
| | Female | 12 | 2024 | 75540 | 0.180 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 209 | 0.180 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2025 | 353 | 0.170 |
Why?
| | Homeostasis | 2 | 2018 | 636 | 0.170 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2023 | 1241 | 0.170 |
Why?
| | Heterografts | 1 | 2021 | 134 | 0.170 |
Why?
| | Cell Membrane | 1 | 2004 | 720 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2023 | 442 | 0.160 |
Why?
| | Adaptive Immunity | 2 | 2018 | 172 | 0.160 |
Why?
| | Mice, Mutant Strains | 3 | 2012 | 306 | 0.160 |
Why?
| | Quinoxalines | 1 | 2020 | 67 | 0.160 |
Why?
| | Immunoglobulin lambda-Chains | 2 | 2015 | 9 | 0.160 |
Why?
| | Immunotherapy | 2 | 2022 | 643 | 0.160 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2023 | 438 | 0.160 |
Why?
| | Male | 10 | 2025 | 69893 | 0.150 |
Why?
| | Endothelial Cells | 1 | 2025 | 813 | 0.150 |
Why?
| | Viral Proteins | 1 | 2002 | 369 | 0.150 |
Why?
| | Age Factors | 3 | 2013 | 3278 | 0.150 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2000 | 208 | 0.150 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 153 | 0.150 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2019 | 173 | 0.140 |
Why?
| | Stem Cells | 2 | 2002 | 603 | 0.140 |
Why?
| | Lymphopoiesis | 1 | 2018 | 26 | 0.140 |
Why?
| | Liver | 2 | 2025 | 1815 | 0.140 |
Why?
| | Liver Neoplasms | 1 | 2025 | 740 | 0.140 |
Why?
| | beta Catenin | 1 | 2020 | 258 | 0.140 |
Why?
| | Receptors, Complement 3d | 1 | 2019 | 140 | 0.140 |
Why?
| | Immunity, Innate | 2 | 2018 | 852 | 0.140 |
Why?
| | Bile Ducts | 1 | 2018 | 67 | 0.140 |
Why?
| | Piperazines | 1 | 2020 | 371 | 0.140 |
Why?
| | Retroviridae | 1 | 2018 | 103 | 0.140 |
Why?
| | Xenograft Model Antitumor Assays | 4 | 2022 | 903 | 0.140 |
Why?
| | Transduction, Genetic | 1 | 2018 | 135 | 0.140 |
Why?
| | Herpesvirus 4, Human | 1 | 2018 | 165 | 0.140 |
Why?
| | Antibodies | 3 | 2015 | 411 | 0.130 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2018 | 98 | 0.130 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2019 | 211 | 0.130 |
Why?
| | Allergens | 1 | 2020 | 401 | 0.130 |
Why?
| | Interleukins | 1 | 2018 | 250 | 0.130 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 260 | 0.130 |
Why?
| | Membrane Glycoproteins | 2 | 2015 | 501 | 0.130 |
Why?
| | Genetic Vectors | 1 | 2018 | 336 | 0.130 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2019 | 193 | 0.130 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2018 | 189 | 0.120 |
Why?
| | B-Cell Activating Factor | 2 | 2018 | 21 | 0.120 |
Why?
| | Phenotype | 2 | 2021 | 3172 | 0.120 |
Why?
| | Genes, bcl-2 | 2 | 2018 | 22 | 0.120 |
Why?
| | HIV Infections | 3 | 2020 | 2967 | 0.120 |
Why?
| | Receptors, Lysosphingolipid | 3 | 2010 | 15 | 0.110 |
Why?
| | Antibody Affinity | 2 | 2012 | 60 | 0.110 |
Why?
| | Histones | 1 | 2020 | 638 | 0.110 |
Why?
| | VDJ Recombinases | 3 | 2004 | 4 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2019 | 719 | 0.110 |
Why?
| | Graft Rejection | 2 | 2021 | 546 | 0.110 |
Why?
| | Immunophenotyping | 1 | 2015 | 327 | 0.110 |
Why?
| | Heart Transplantation | 1 | 2021 | 714 | 0.110 |
Why?
| | Macrophages, Peritoneal | 2 | 2011 | 97 | 0.110 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2020 | 1430 | 0.110 |
Why?
| | Fibronectins | 2 | 2011 | 136 | 0.100 |
Why?
| | Rotavirus | 1 | 2013 | 20 | 0.100 |
Why?
| | Toll-Like Receptors | 2 | 2020 | 189 | 0.100 |
Why?
| | Gene Targeting | 2 | 2006 | 83 | 0.100 |
Why?
| | Adoptive Transfer | 2 | 2013 | 223 | 0.100 |
Why?
| | Animals, Newborn | 2 | 2018 | 866 | 0.100 |
Why?
| | Azospirillum brasilense | 1 | 1993 | 1 | 0.100 |
Why?
| | Glutamate Synthase | 1 | 1993 | 2 | 0.100 |
Why?
| | Antibody Diversity | 3 | 2007 | 16 | 0.100 |
Why?
| | Clonal Selection, Antigen-Mediated | 1 | 2012 | 4 | 0.100 |
Why?
| | Kinetics | 3 | 2012 | 1651 | 0.100 |
Why?
| | Lymphocyte Count | 1 | 2013 | 167 | 0.100 |
Why?
| | Genes, Bacterial | 1 | 1993 | 165 | 0.100 |
Why?
| | HIV Antibodies | 1 | 2013 | 63 | 0.100 |
Why?
| | Lymphocyte Depletion | 1 | 2013 | 136 | 0.090 |
Why?
| | Toll-Like Receptor 7 | 1 | 2012 | 40 | 0.090 |
Why?
| | fas Receptor | 1 | 2012 | 97 | 0.090 |
Why?
| | Receptors, Thromboxane | 1 | 2011 | 4 | 0.090 |
Why?
| | Rho Guanine Nucleotide Exchange Factors | 5 | 2011 | 25 | 0.090 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 415 | 0.090 |
Why?
| | Immunoglobulin mu-Chains | 2 | 2004 | 8 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 466 | 0.090 |
Why?
| | Lupus Nephritis | 1 | 2012 | 67 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 2156 | 0.090 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2015 | 430 | 0.090 |
Why?
| | Mice, Inbred NOD | 3 | 2022 | 599 | 0.090 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2011 | 133 | 0.090 |
Why?
| | Hematopoietic Stem Cells | 3 | 2011 | 411 | 0.090 |
Why?
| | Cell Communication | 1 | 2013 | 316 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 805 | 0.080 |
Why?
| | Dendritic Cells | 2 | 2012 | 502 | 0.080 |
Why?
| | Cholestasis | 1 | 2013 | 209 | 0.080 |
Why?
| | Friend murine leukemia virus | 1 | 2010 | 31 | 0.080 |
Why?
| | Cytidine Deaminase | 1 | 2010 | 61 | 0.080 |
Why?
| | Reperfusion Injury | 1 | 2013 | 292 | 0.080 |
Why?
| | Integrin alpha5beta1 | 1 | 2010 | 9 | 0.080 |
Why?
| | Self Tolerance | 1 | 2010 | 27 | 0.080 |
Why?
| | Proprotein Convertases | 1 | 2010 | 16 | 0.080 |
Why?
| | Integrins | 2 | 2007 | 95 | 0.080 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2010 | 145 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1786 | 0.080 |
Why?
| | Serine Endopeptidases | 1 | 2010 | 126 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2021 | 6257 | 0.080 |
Why?
| | Matrix Metalloproteinases | 1 | 2010 | 95 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2010 | 196 | 0.070 |
Why?
| | Immunity | 1 | 2010 | 139 | 0.070 |
Why?
| | Kidney Diseases | 1 | 2013 | 408 | 0.070 |
Why?
| | Immunity, Active | 1 | 2008 | 11 | 0.070 |
Why?
| | Molecular Sequence Data | 4 | 2013 | 2917 | 0.070 |
Why?
| | Interleukin-6 | 2 | 2023 | 777 | 0.070 |
Why?
| | Gene Rearrangement, B-Lymphocyte, Light Chain | 2 | 1998 | 4 | 0.070 |
Why?
| | Macrophages, Alveolar | 1 | 2011 | 395 | 0.070 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 757 | 0.070 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 465 | 0.070 |
Why?
| | Mice, Nude | 2 | 2020 | 689 | 0.070 |
Why?
| | Virus Replication | 1 | 2010 | 531 | 0.070 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2007 | 19 | 0.070 |
Why?
| | YY1 Transcription Factor | 1 | 2007 | 22 | 0.070 |
Why?
| | Recombination, Genetic | 4 | 2006 | 206 | 0.070 |
Why?
| | Kidney Transplantation | 1 | 2013 | 677 | 0.060 |
Why?
| | Bronchial Hyperreactivity | 1 | 2007 | 104 | 0.060 |
Why?
| | Cell Line | 3 | 2020 | 2879 | 0.060 |
Why?
| | Melanoma | 1 | 2013 | 792 | 0.060 |
Why?
| | I-kappa B Kinase | 1 | 2006 | 54 | 0.060 |
Why?
| | Th2 Cells | 1 | 2007 | 177 | 0.060 |
Why?
| | Binding Sites, Antibody | 1 | 2005 | 42 | 0.060 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2006 | 166 | 0.060 |
Why?
| | Rats | 1 | 2014 | 5594 | 0.060 |
Why?
| | Cell Line, Tumor | 3 | 2019 | 3487 | 0.060 |
Why?
| | Diethylnitrosamine | 1 | 2025 | 6 | 0.060 |
Why?
| | HIV Envelope Protein gp120 | 2 | 2017 | 61 | 0.060 |
Why?
| | Kidney | 1 | 2013 | 1475 | 0.060 |
Why?
| | DNA Nucleotidyltransferases | 2 | 2002 | 11 | 0.060 |
Why?
| | Carbon Tetrachloride | 1 | 2025 | 13 | 0.060 |
Why?
| | src-Family Kinases | 1 | 2005 | 94 | 0.060 |
Why?
| | Lymphoma, B-Cell | 1 | 2006 | 131 | 0.060 |
Why?
| | Immunoglobulin Class Switching | 2 | 2010 | 21 | 0.060 |
Why?
| | Cell Movement | 2 | 2008 | 982 | 0.050 |
Why?
| | Cell Division | 2 | 2004 | 792 | 0.050 |
Why?
| | Clonal Deletion | 1 | 2004 | 16 | 0.050 |
Why?
| | Base Sequence | 3 | 2004 | 2169 | 0.050 |
Why?
| | Oligodeoxyribonucleotides | 2 | 2015 | 143 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 1999 | 873 | 0.050 |
Why?
| | Monitoring, Immunologic | 1 | 2023 | 22 | 0.050 |
Why?
| | Mutagenesis | 1 | 2004 | 182 | 0.050 |
Why?
| | Hematopoiesis | 1 | 2004 | 193 | 0.050 |
Why?
| | Immunoglobulin D | 1 | 2022 | 30 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2025 | 283 | 0.050 |
Why?
| | Lectins, C-Type | 2 | 2014 | 63 | 0.050 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 2 | 2014 | 97 | 0.050 |
Why?
| | Crosses, Genetic | 1 | 2002 | 133 | 0.050 |
Why?
| | Transplantation, Heterologous | 1 | 2022 | 193 | 0.050 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2022 | 28 | 0.050 |
Why?
| | NF-kappa B | 1 | 2006 | 690 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2013 | 391 | 0.050 |
Why?
| | Leukosialin | 2 | 1999 | 13 | 0.040 |
Why?
| | Chimerism | 1 | 2021 | 33 | 0.040 |
Why?
| | Interferons | 1 | 2022 | 195 | 0.040 |
Why?
| | Phosphorylation | 1 | 2005 | 1758 | 0.040 |
Why?
| | Pneumonia | 1 | 2007 | 656 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 985 | 0.040 |
Why?
| | Sialoglycoproteins | 2 | 1999 | 160 | 0.040 |
Why?
| | Inflammation | 2 | 2022 | 2891 | 0.040 |
Why?
| | Lymphocyte Subsets | 1 | 2021 | 88 | 0.040 |
Why?
| | Cytoskeleton | 1 | 2022 | 194 | 0.040 |
Why?
| | Hemagglutination | 1 | 2020 | 8 | 0.040 |
Why?
| | Lymphoid Tissue | 1 | 2021 | 80 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 365 | 0.040 |
Why?
| | COS Cells | 1 | 2020 | 180 | 0.040 |
Why?
| | Homozygote | 1 | 2000 | 201 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2006 | 1156 | 0.040 |
Why?
| | Perforin | 1 | 2019 | 19 | 0.040 |
Why?
| | RNA, Viral | 1 | 2023 | 691 | 0.040 |
Why?
| | Heterozygote | 1 | 2000 | 308 | 0.040 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2019 | 50 | 0.040 |
Why?
| | Exocytosis | 1 | 2019 | 88 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 2152 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 956 | 0.040 |
Why?
| | Viral Tropism | 1 | 2018 | 34 | 0.040 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 2018 | 52 | 0.040 |
Why?
| | Antigens, Nuclear | 1 | 1998 | 16 | 0.040 |
Why?
| | Lipopolysaccharides | 2 | 2015 | 887 | 0.040 |
Why?
| | Virus Activation | 1 | 2018 | 86 | 0.040 |
Why?
| | Virus Latency | 1 | 2018 | 80 | 0.030 |
Why?
| | Immunization | 1 | 2020 | 405 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2022 | 652 | 0.030 |
Why?
| | Mutagenesis, Insertional | 1 | 1997 | 65 | 0.030 |
Why?
| | Leukocyte Common Antigens | 1 | 1997 | 90 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2020 | 1038 | 0.030 |
Why?
| | Tamoxifen | 1 | 2018 | 203 | 0.030 |
Why?
| | Antibody Specificity | 2 | 2013 | 187 | 0.030 |
Why?
| | Cross Reactions | 1 | 2017 | 133 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 370 | 0.030 |
Why?
| | HIV | 1 | 2018 | 247 | 0.030 |
Why?
| | Immunoglobulin Light Chains, Surrogate | 1 | 1996 | 1 | 0.030 |
Why?
| | DNA Helicases | 1 | 1998 | 141 | 0.030 |
Why?
| | Lung | 1 | 2010 | 4127 | 0.030 |
Why?
| | Green Fluorescent Proteins | 2 | 2011 | 401 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 368 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 447 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1996 | 504 | 0.030 |
Why?
| | Syk Kinase | 1 | 2015 | 21 | 0.030 |
Why?
| | Cell Adhesion | 2 | 2007 | 468 | 0.030 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2015 | 42 | 0.030 |
Why?
| | Genes, Reporter | 2 | 2006 | 272 | 0.030 |
Why?
| | GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2014 | 8 | 0.030 |
Why?
| | B7-2 Antigen | 1 | 2014 | 28 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 89 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1726 | 0.030 |
Why?
| | Interleukin-4 | 1 | 2015 | 215 | 0.030 |
Why?
| | Neoplastic Processes | 1 | 2013 | 4 | 0.030 |
Why?
| | Chromosomes, Bacterial | 1 | 1993 | 9 | 0.030 |
Why?
| | Restriction Mapping | 1 | 1993 | 76 | 0.020 |
Why?
| | Genes, Immunoglobulin Heavy Chain | 1 | 2013 | 9 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2013 | 159 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1471 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 1998 | 716 | 0.020 |
Why?
| | Calcium | 1 | 2019 | 1190 | 0.020 |
Why?
| | Macrophages | 1 | 2021 | 1559 | 0.020 |
Why?
| | Operon | 1 | 1993 | 68 | 0.020 |
Why?
| | AIDS Vaccines | 1 | 2013 | 53 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 1993 | 224 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1993 | 532 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2011 | 90 | 0.020 |
Why?
| | Autocrine Communication | 1 | 2011 | 40 | 0.020 |
Why?
| | Apoptosis | 1 | 2020 | 2571 | 0.020 |
Why?
| | Species Specificity | 1 | 2013 | 577 | 0.020 |
Why?
| | Ficoll | 1 | 2010 | 5 | 0.020 |
Why?
| | Retroviridae Infections | 1 | 2010 | 48 | 0.020 |
Why?
| | Toll-Like Receptor 3 | 1 | 2010 | 29 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 393 | 0.020 |
Why?
| | Poly I-C | 1 | 2010 | 63 | 0.020 |
Why?
| | Receptors, IgG | 1 | 2010 | 77 | 0.020 |
Why?
| | Arthritis, Rheumatoid | 1 | 1999 | 1178 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2010 | 328 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2010 | 270 | 0.020 |
Why?
| | Escherichia coli | 1 | 1993 | 835 | 0.020 |
Why?
| | DNA Methylation | 2 | 2007 | 640 | 0.020 |
Why?
| | Leukocytes | 1 | 2010 | 306 | 0.020 |
Why?
| | Cell Membrane Structures | 1 | 2007 | 5 | 0.020 |
Why?
| | Epitopes | 1 | 2010 | 477 | 0.020 |
Why?
| | RGS Proteins | 1 | 2007 | 17 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2010 | 560 | 0.020 |
Why?
| | Ligands | 1 | 2010 | 667 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2007 | 120 | 0.020 |
Why?
| | Vaccines | 1 | 2013 | 405 | 0.020 |
Why?
| | Gene Expression | 2 | 2006 | 1490 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1602 | 0.020 |
Why?
| | PAX5 Transcription Factor | 1 | 2007 | 14 | 0.020 |
Why?
| | Molecular Weight | 1 | 2007 | 327 | 0.020 |
Why?
| | Bronchial Provocation Tests | 1 | 2007 | 50 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2010 | 649 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2007 | 136 | 0.020 |
Why?
| | Cell Polarity | 1 | 2007 | 140 | 0.020 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2006 | 16 | 0.020 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 238 | 0.020 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2006 | 33 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2010 | 837 | 0.020 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2006 | 23 | 0.020 |
Why?
| | Interleukin-7 | 1 | 2006 | 62 | 0.020 |
Why?
| | Genetic Markers | 1 | 2007 | 342 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2007 | 308 | 0.020 |
Why?
| | Protein Transport | 1 | 2007 | 448 | 0.020 |
Why?
| | Protein Kinase C-delta | 1 | 2006 | 48 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2006 | 122 | 0.020 |
Why?
| | Hyperplasia | 1 | 2006 | 174 | 0.010 |
Why?
| | Genotype | 1 | 2010 | 1862 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2007 | 858 | 0.010 |
Why?
| | Polymerase Chain Reaction | 2 | 1999 | 1052 | 0.010 |
Why?
| | Gene Deletion | 1 | 2006 | 388 | 0.010 |
Why?
| | Cell Lineage | 1 | 2006 | 351 | 0.010 |
Why?
| | DNA Nucleotidylexotransferase | 1 | 2004 | 12 | 0.010 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2004 | 14 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 2004 | 93 | 0.010 |
Why?
| | Luminescent Proteins | 1 | 2004 | 181 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 11462 | 0.010 |
Why?
| | Chromatin | 1 | 2007 | 533 | 0.010 |
Why?
| | DNA Primers | 1 | 2004 | 508 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2006 | 607 | 0.010 |
Why?
| | Extracellular Matrix Proteins | 1 | 2004 | 157 | 0.010 |
Why?
| | RNA-Binding Proteins | 1 | 2006 | 447 | 0.010 |
Why?
| | Epigenesis, Genetic | 1 | 2007 | 655 | 0.010 |
Why?
| | Down-Regulation | 1 | 2004 | 638 | 0.010 |
Why?
| | Homeodomain Proteins | 1 | 2004 | 512 | 0.010 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 1999 | 17 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 22027 | 0.010 |
Why?
| | Ku Autoantigen | 1 | 1998 | 10 | 0.010 |
Why?
| | Organ Specificity | 1 | 1999 | 311 | 0.010 |
Why?
| | Child | 1 | 2018 | 22313 | 0.010 |
Why?
| | Genes, RAG-1 | 1 | 1997 | 12 | 0.010 |
Why?
| | Gene Rearrangement | 1 | 1999 | 148 | 0.010 |
Why?
| | Antigen Presentation | 1 | 1999 | 219 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 1998 | 188 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1999 | 817 | 0.010 |
Why?
|
|
Pelanda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|